Cargando…
Variation in charges for 10 common blood tests in California hospitals: a cross-sectional analysis
OBJECTIVES: To determine the variation in charges for 10 common blood tests across California hospitals in 2011, and to analyse the hospital and market-level factors that may explain any observed variation. DESIGN, SETTING AND PARTICIPANTS: We conducted a cross-sectional analysis of the degree of ch...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139626/ https://www.ncbi.nlm.nih.gov/pubmed/25127708 http://dx.doi.org/10.1136/bmjopen-2014-005482 |
Sumario: | OBJECTIVES: To determine the variation in charges for 10 common blood tests across California hospitals in 2011, and to analyse the hospital and market-level factors that may explain any observed variation. DESIGN, SETTING AND PARTICIPANTS: We conducted a cross-sectional analysis of the degree of charge variation between hospitals for 10 common blood tests using charge data reported by all non-federal California hospitals to the California Office of Statewide Health Planning and Development in 2011. OUTCOME MEASURES: Charges for 10 common blood tests at California hospitals during 2011. RESULTS: We found that charges for blood tests varied significantly between California hospitals. For example, charges for a lipid panel ranged from US$10 to US$10 169, a thousand-fold difference. Although government hospitals and teaching hospitals were found to charge significantly less than their counterparts for many blood tests, few other hospital characteristics and no market-level predictors significantly predicted charges for blood tests. Our models explained, at most, 21% of the variation between hospitals in charges for the blood test in question. CONCLUSIONS: These findings demonstrate the seemingly arbitrary nature of the charge setting process, making it difficult for patients to act as true consumers in this era of ‘consumer-directed healthcare.’ |
---|